Page last updated: 2024-09-05

sdz mrl 953 and Neoplasms

sdz mrl 953 has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engelhardt, R; Färber, L; Gaboriau, E; Galanos, C; Haus, U; Kiani, A; Knopf, HP; Mertelsmann, R; Otto, F; Seiz, A; Stütz, P; Tschiersch, A1

Trials

1 trial(s) available for sdz mrl 953 and Neoplasms

ArticleYear
Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients.
    Blood, 1997, Aug-15, Volume: 90, Issue:4

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Cytokines; Double-Blind Method; Down-Regulation; Endotoxins; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Lipid A; Lipopolysaccharides; Middle Aged; Neoplasms; Neutrophils; Prospective Studies; Salmonella; Tumor Necrosis Factor-alpha

1997